TechNation Radio Podcast

On this episode Tech Nation broadcasts from BIO 2015, the international biotechnology conference in Philadelphia. The buzz centers around a new focus on patient-oriented drug development, as well as real success with cancer immunotherapies and deep progress in rare diseases. There are signs that the industry is maturing, finally delivering on the promise of bio-pharmaceutical drugs on an unprecedented scale, while the effect of patents on emerging products is a concern, as getting drugs to humans is different than patenting a widget.Dr. Moira Gunn speaks with:- JIM GREENWOOD President and CEO of BIO, the Biotechnology Industry Organization as Tech Nation- PAUL HASTINGS Chairman and President, OncoMed Pharmaceuticals and Chairnman, BIO Board of Directors’ Patient Advocacy CommitteeMIKE MAY, Editorial Director of Scientific American WorldView and YALI FRIEDMAN is the head of data analytics for Scientific American WorldView, and- GARETH WILLIAMS Partner and Patent Attorney, Marks & Clerk International Intellectual Property Firm and Editor-in-Chief, Marks & Clerk Life Sciences Report 2015 “From Rare to Routine: Medicines for Rare Diseases, Vaccines & Antibiotics.”

On this week’s Tech Nation, Moira speaks with Stanford’s DR. TINA SEELIG about her book “INSIGHT OUTSIGHT OUT: Get Ideas Out of your Head and into the World.” We'll find out the difference between imagination, creativity, and innovation.Then on BioTech Nation, it’s all about “wearables” – personal technology we can strap on our wrists, or our bodies that can help you and your doctor monitor your health. DR. DANIEL KRAFT is the Chair of Medicine at Singularity University and the Founder of Exponential Medicine. We'll hear what's coming and what it means for all of us.

On this week’s Tech Nation, Moira speaks withLEEROM SEGAL, President & CEO, Klick Health and the author of “The Decoded Company.” With all the information everyone access to and generates all the time, it turns out that the ecosystem of a company is more important than its organization chart.Then on BioTech Nation, we discuss decoding a whole human genome, and doing it fast with PIETER VAN ROOYEN, President & CEO of Edico Genome. Then we'll discuss the role of voluntary patient registries to better treat long term chronic disease, such as heart disease and Rheumatoid Arthritis with DR. STEFAN LARSSON, Partner, Boston Consulting Group, Stockholm and Dr. DR. SOFIA ERNESTAM, Senior Physician in Rheumatology, Karolinska Institute

On this week’s Tech Nation, Moira speaks with DAN MOTE, the President of the National Academy of Engineering. They talk about the difference between technology and engineering. Then on BioTech Nation, SIR JOHN CHISHOLM, head of Genomics England and the 100,000 Genomes Project

On this week’s Tech Nation, Moira speaks with GEOFF MOORE, Strategy ConsultantAuthor, “CROSSING THE CHASM: Marketing and Selling Disruptive Products to Mainstream Customers, third edition” about what happens to a hot tech companies that get a lot of interest early … and then never make it. Then on BioTech Nation, ANNE WOJCICKI, the co-founder and CEO of 23andMe. From DNA analysis and a new grant from the National Institutes of Health to a new partnership with Pfizer on Crohn's Disease, there's more to 23andMe than meets the eye.

On this week’s Tech Nation, Moira speaks with DR. BESSEL VAN DER KOLK, the founder and medical director of the Trauma Center in Boston, and a professor at psychiatry at Boston University Medical Center. He’s written “The Body Keeps the Score: Brain, Mind and Body in the Healing of Trauma.” #medecine #braintrauma #scienceThen on BioTech Nation, we talk to MARTIN McGLYNN, President & CEO, StemCells, Inc. about initial attempts at stem cell treatments for such different conditions as spinal cord injury, PMD (Pelizaeus Merzbacher Disease) and age-related macular degeneration begin to show promise. #spinalcordinjury #pmd #stemcells #health

On this week’s Tech Nation, Moira speaks withMcGill professor and behavioral neuroscientist DANIEL LEVITIN about “The Organized Mind: Thinking Straight in the Age of Information Overload.” Our brains need to operate differently today than they ever did before.Then on BioTech Nation, “The most important genome in your body may not be your own.” So says MOHAN IYER, the Chief Business Officer of Second Genome. We talk about our microbiomes – the trillions of microbes which populate our bodies, as well as the impact they may have on us.

On this week’s Tech Nation, Moira speaks witha panel of esteemed professors, who will explain each of the 2014 Nobel prizes, and why they are important.These include:GENARO PADILLA English ProfessorUC Berkeley, STEPHEN ZUNES Politics Professor University of San Francisco,JOE FARRELL Economics Professor UC Berkeley,CONNIE CHANG Electrical Engineering and Computer Sciences Professor UC Berkeley,Jai Yu Neuroscientist UC San Francisco Center for Integrative Neuroscience

On this week’s Tech Nation, Moira speaks withLIOR ZOREF, former Microsoft vice president of marketing for consumer and online services. He’ll tell us about his book: “Mindsharing, The Art of Crowdsourcing Everything.”Then on BioTech Nation, DR JOE MILETICH , the Senior Vice President for R&D at Amgen. We’ll hear about “oncolytic viruses” specifically designed to go after cancers, and advances in lowering cholesterol, based on genetics.

On this week’s Tech Nation, Moira speaks withventure capitalist JUAN ENRIQUEZ talks about “Evolving Ourselves: How Unnatural Selection and Nonrandom Mutation are Changing Life on Earth.”Then on BioTech Nation, we talk to DR BARBARA FOX CEO, Avaxia Biologics about a treatment for pediatric Inflammatory Bowel Disease and to DR CRAIG AUDET Head of Global Regulatory Affairs, Arena Pharmaceuticalsabout an FDA-approved obesity drug which is also being considered for smoking cessation.